TransCode Therapeutics, Inc.TransCode Therapeutics, Inc.TransCode Therapeutics, Inc.

TransCode Therapeutics, Inc.

No trades
See on Supercharts

Price target

3.000.000.00%
The 1 analyst offering 1 year price forecasts for RNAZ have a max estimate of — and a min estimate of —.

Analyst rating

Based on 1 analyst giving stock ratings to RNAZ in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


In the next quarter TransCode Therapeutics, Inc. revenue is expected to reach ‪300.00 K‬ USD. Check out TransCode Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, RNAZ price target is 3.00 USD with a max estimate of 3.00 USD and a min estimate of 3.00 USD. Check if this forecast comes true in a year, meanwhile watch TransCode Therapeutics, Inc. stock price chart and keep track of the current situation with RNAZ news and stock market news.